CinnoRa 40mg/0.8ml
Couldn't load pickup availability
You can promote by sharing on social networks on the links.
Product Description
CinnoRA 40mg/0.8ml is a biological medicine manufactured by CinnaGen Company. It contains Adalimumab, a monoclonal antibody that helps control inflammation in certain autoimmune conditions.
Product Overview
Product Name: CinnoRA 40mg/0.8ml
Strength: 40mg/0.8ml
Form: Subcutaneous Injection
Generic Name: Adalimumab
Manufacturer: CinnaGen Company
Used For: Treatment of selected autoimmune conditions, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and certain inflammatory bowel and skin conditions.
Prescription Required: Yes — specialist supervision required
Ingredients & How They Work
Adalimumab 40mg: A tumour necrosis factor (TNF) inhibitor that blocks TNF-alpha, a protein involved in inflammation. This helps reduce inflammatory activity in autoimmune conditions.
Key Benefits
-
Helps control inflammation in autoimmune diseases.
-
May reduce joint pain and swelling.
-
Helps manage symptoms of selected inflammatory conditions.
How to Use
-
Administer by subcutaneous injection according to specialist instructions.
-
Follow the prescribed injection schedule.
-
Do not use without appropriate medical assessment and monitoring.
-
Follow the manufacturer's instructions for injection technique and storage.
Side Effects & Precautions
Possible Side Effects: Injection-site reactions, headache, rash, and increased risk of infections.
Precautions:
-
Screening for tuberculosis and hepatitis B may be required before treatment.
-
Inform your doctor about current or recent infections.
-
Live vaccines may need to be avoided during treatment.
-
Seek medical attention for fever, persistent cough, breathing difficulty, or signs of serious infection.
Storage Instructions
Store in a refrigerator at 2°C–8°C. Do not freeze. Protect from light and follow the manufacturer's instructions for transport and handling.